SU1697755A1 - Method for curing the vasomotor rhinosinusitis - Google Patents

Method for curing the vasomotor rhinosinusitis Download PDF

Info

Publication number
SU1697755A1
SU1697755A1 SU884429543A SU4429543A SU1697755A1 SU 1697755 A1 SU1697755 A1 SU 1697755A1 SU 884429543 A SU884429543 A SU 884429543A SU 4429543 A SU4429543 A SU 4429543A SU 1697755 A1 SU1697755 A1 SU 1697755A1
Authority
SU
USSR - Soviet Union
Prior art keywords
vasomotor
rhinosinusitis
curing
remission
terms
Prior art date
Application number
SU884429543A
Other languages
Russian (ru)
Inventor
Юрий Александрович Лоцманов
Анатолий Борисович Князев
Михаил Николаевич Кольцов
Original Assignee
Саратовский государственный медицинский институт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Саратовский государственный медицинский институт filed Critical Саратовский государственный медицинский институт
Priority to SU884429543A priority Critical patent/SU1697755A1/en
Application granted granted Critical
Publication of SU1697755A1 publication Critical patent/SU1697755A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относитс  к медицине, а именно к оториноларингологии. Целью изобретени   вл етс  удлинение сроков ремиссии . Цель реализуетс  тем, что дл  эндоназальных инъекций используют гемо- лизированную аутокровь. Преимуществом способа  вл етс  стимулирующее действие на различные системы организма, в результате чего удлин ютс  сроки ремиссии.The invention relates to medicine, namely to otolaryngology. The aim of the invention is to lengthen the terms of remission. The goal is realized by using hemolyzed autologous blood for endonasal injections. The advantage of the method is a stimulating effect on various systems of the body, as a result of which the terms of remission are extended.

Description

Изобретение относитс  к медицине, а именно к оториноларингологии.The invention relates to medicine, namely to otolaryngology.

Целью изобретени   вл етс  удлинение сроков ремиссии.The aim of the invention is to lengthen the terms of remission.

Способ выполн ют следующим образом.The method is performed as follows.

В основание прикреплени  передчих концов обеих нижних носовых раковин одновременно с обеих сторон, один раз в сутки производ т инъекции гемолизированной аутокрови в течение 10-12 дней.At the base of attachment of the front ends of both lower nasal conchas on both sides simultaneously, hemolyzed autologous blood is injected once a day for 10-12 days.

Конкретный пример выполнени  способа.A specific example of the method.

Больна  П., 60 лет, больна 2 года. Диагноз - вазомоторный риносинуит, аллергиче- ска  форма. Лечение проведено по предложенной методике. Отмечено исчезновение заложенности носа, свободное носовое дыхание, исчезновение выделений из носа. Через 3 мес. обострени  не наблюдалось , эффект сохран лс .Ill P., 60 years old, ill for 2 years. The diagnosis is vasomotor rhinosinuitis, an allergic form. The treatment was carried out according to the proposed method. Marked disappearance of nasal congestion, free nasal breathing, disappearance of nasal discharge. After 3 months no exacerbation was observed, the effect persisted.

Преимущество данного способа в том, что продукты распада форменных элементов крови, содержащиес  в термоизолированной аутокрови обладают выраженным стимулирующим действием на различные системы организма, в результате чего повышаетс  эффективность лечени  и удлин ютс  сроки ремиссии.The advantage of this method is that the decomposition products of blood cells contained in a thermally insulated autologous blood have a pronounced stimulating effect on various systems of the body, as a result of which the effectiveness of treatment increases and the duration of remission is extended.

Claims (1)

Формула изобретени Invention Formula Способ лечени  вазомоторного риноси- нуита путем эндоназальных инъекций в основание прикреплений передних концов обеих нижних носовых раковин препаратов аутокрови, отличающийс  тем, что, с целью удлинени  сроков ремиссии, дл  инъекций используют гемолизированную аутокровь.A method of treating vasomotor rhinosynuitis by endonasal injections into the base of attachments of the front ends of both lower nasal concha of autoblood preparations, characterized in that hemolyzed autologous blood is used for injection in order to prolong the remission periods. ёyo ОABOUT юYu х| VI СЛ СПx | VI SL SP
SU884429543A 1988-05-23 1988-05-23 Method for curing the vasomotor rhinosinusitis SU1697755A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU884429543A SU1697755A1 (en) 1988-05-23 1988-05-23 Method for curing the vasomotor rhinosinusitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU884429543A SU1697755A1 (en) 1988-05-23 1988-05-23 Method for curing the vasomotor rhinosinusitis

Publications (1)

Publication Number Publication Date
SU1697755A1 true SU1697755A1 (en) 1991-12-15

Family

ID=21376764

Family Applications (1)

Application Number Title Priority Date Filing Date
SU884429543A SU1697755A1 (en) 1988-05-23 1988-05-23 Method for curing the vasomotor rhinosinusitis

Country Status (1)

Country Link
SU (1) SU1697755A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3354B (en) 1993-06-29 1995-07-25 Sigitas Pakenas Method for making of wood frame

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Авторское свидетельство СССР № 1438797, кл. А 61 В 17/00, 1987. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3354B (en) 1993-06-29 1995-07-25 Sigitas Pakenas Method for making of wood frame

Similar Documents

Publication Publication Date Title
GEP20012413B (en) Novel Substituted Cyclic Amino Acids as Pharmaceutical Agents
BG94837A (en) O-METHYL DERIVATIVES OF AZITHROMYCIN A, METHOD FOR THEIR PREPARATION AND THEIR APPLICATION AS PHARMACEUTICAL PREPARATIONS
DE69230112D1 (en) ADVANCED DRUG DELIVERY SYSTEM AND METHOD FOR TREATING PSYCHIATRIC, NEUROLOGICAL AND OTHER DISEASES WITH CARBAMAZEPINE
DK77090A (en) Immunomodulatory AZASPIRANS
ATE254926T1 (en) USE OF A CONSENSUS INTERFERON TO REDUCE ADVERSE EFFECTS IN THE INTERFERON TREATMENT OF VIRAL HEPATITES.
ES2160707T3 (en) COMPOSITIONS THAT INCLUDE DETERIORATING AGENTS OF DNA AND P53.
RU95108243A (en) Amide derivatives of valpronic and 2-valproenic acids, pharmaceutical composition, and methods of medical treatment
DE3876125D1 (en) TREATMENT OF HUMAN VIRAL INFECTION BY DOUBLE-STRAND RNA COMBINED WITH VIRAL INHIBITORS.
ATE322283T1 (en) TRANSDERMAL USE OF SECRETIN TO TREAT AUTISM
ATE219519T1 (en) RECOMBINANT THERAPIES FOR INFECTIONS AND HYPERPROLIFERATIVE DISORDERS
ES2114073T3 (en) REGENERATION OF THE LIVER INDUCED BY MORPHOGEN.
SU1697755A1 (en) Method for curing the vasomotor rhinosinusitis
DK0679079T3 (en) Solution containing IGF-1
ES2036526T3 (en) INTERFERON COMPOSITIONS.
ATE302011T1 (en) PONAZURIL FOR THE TREATMENT OF DISEASES CAUSED BY COCCIDIA NEUROLOGICAL AND ABORTIGENICS
NO945031L (en) Use of a hymenopteran drug to prepare a drug for the treatment of DNA virus infections
DE60017194D1 (en) PROCESS FOR PREPARING CARBAPENEM ANTIBIOTIC PREPARATIONS
DE1792555A1 (en) Process for the preparation of gamma globulin suitable for intravenous use
DE3783122D1 (en) USE OF RECOMBINED HUMAN ALPHA INTERFERON FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR TREATING THE AIDS VIRUS.
ATE24834T1 (en) USE OF BETA-(1-ADAMANTYL)-ALPHA, ALPHADIMETHYLETHYLAMINE IN THE MANUFACTURE OF A MEDICATION FOR THE TREATMENT OF EXTERNAL OTITIS IN DOGS.
RU2017485C1 (en) Method for treatment of leptospirosis at cattle
ATE335494T1 (en) USE OF N-GLYCOLNEURAMINE ACID AND DERIVATIVES THEREOF FOR PRODUCING A MEDICATION FOR THE TREATMENT OF HIV INFECTIONS
KR900701311A (en) How to treat squamous cell carcinoma by administering recombinant human α-interferon intralesionally
RU96122371A (en) METHOD FOR TREATING ENDOGENOUS AND POSTOPERATIVE ANALYSIS
SU1702412A1 (en) Method for modeling trypsin deficiency in vivo